Literature DB >> 32209791

Current Standards in the Endoscopic Management of Bladder Cancer: A Survey Evaluation among Urologists in German-Speaking Countries.

Rodrigo Suarez-Ibarrola1, Simon Hein2, Erik Farin3, Frank Waldbillig4, Maximilian C Kriegmair4, Manuel Ritter5, Hans C Klingler6,7, Thomas R W Herrmann8, Christian Gratzke2, Arkadiusz Miernik2.   

Abstract

INTRODUCTION: To assess the current diagnostic, treatment, and documentation strategies for bladder cancer (BC) in German-speaking countries.
MATERIALS AND METHODS: A 14-item web-based survey was distributed among members of the German, Austrian, and Swiss Associations of Urology, addressing physicians who perform cystoscopies and transurethral resection of bladder tumors (TURB).
RESULTS: The survey was responded to by 308 of 5,564 urologists with a mean age of 49.5 years (response rate: 5.5%). The majority of participants (57.3%) practice in an outpatient setting. White light cystoscopy only is used by 60.2%, with additional photodynamic diagnosis and narrow band imaging by 36.8 and 12.5%, respectively. Endoscopic findings are documented in written form by 93.5%, followed by image capture (33.7%) and a central data archive (20.8%). Inpatient hospital urologists document cystoscopic findings by freehand drawing (21.4 vs. 11.4%, p = 0.017), and with a fixed bladder scheme (31.3 vs. 7.4%, <0.05) significantly more frequently. Cystoscopic findings are mainly conveyed to other health professionals in written form (77.4%), and significantly more often by inpatient urologists (p < 0.05).
CONCLUSIONS: Significant differences exist in the approach to documenting and communicating cystoscopic BC findings. Accurate graphic documentation of lesions, visualization of the mucosa's totality, and meticulous consultation of previous surgical reports require improvements to reduce recurrence and progression rates.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Bladder cancer; Bladder tumor; Cystoscopy; Endoscopic documentation; Nonmuscle-invasive bladder cancer; Transurethral resection of bladder tumors

Mesh:

Year:  2020        PMID: 32209791     DOI: 10.1159/000506653

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  6 in total

Review 1.  [Enhanced imaging in urological endoscopy].

Authors:  M C Kriegmair; S Hein; D S Schoeb; H Zappe; R Suárez-Ibarrola; F Waldbillig; B Gruene; P-F Pohlmann; F Praus; K Wilhelm; C Gratzke; A Miernik; C Bolenz
Journal:  Urologe A       Date:  2020-12-10       Impact factor: 0.639

2.  How do endoscopic bladder tumor resection techniques affect pathology practice? EAU Section of Uro-Technology (ESUT) and Uropathology (ESUP) survey.

Authors:  Selcuk Guven; Maurizio Colecchia; Pembe Oltulu; Giulia Bonfante; Dmitry Enikeev; Hasan Esen; Thomas Herrmann; Lukas Lusuardi; Salvatore Micali; Bashkar Somani; Andreas Skolarikos; Alberto Breda; Evangelos Liatsikos; Joan Palou Redorta; Ali Serdar Gozen
Journal:  World J Urol       Date:  2022-05-14       Impact factor: 4.226

3.  Reduced Recurrence Rates Are Associated with Photodynamic Diagnostics Compared to White Light after Extended Transurethral Resection of Bladder Tumors.

Authors:  Alexander Marquardt; Mario Richterstetter; Helge Taubert; Arndt Hartmann; Bernd Wullich; Verena Lieb; Laura Bellut; Sven Wach; Hendrik Apel
Journal:  Life (Basel)       Date:  2022-04-26

Review 4.  Explainable artificial intelligence (XAI): closing the gap between image analysis and navigation in complex invasive diagnostic procedures.

Authors:  S O'Sullivan; M Janssen; Andreas Holzinger; Nathalie Nevejans; O Eminaga; C P Meyer; Arkadiusz Miernik
Journal:  World J Urol       Date:  2022-01-27       Impact factor: 3.661

Review 5.  Role of Macroscopic Image Enhancement in Diagnosis of Non-Muscle-Invasive Bladder Cancer: An Analytical Review.

Authors:  Prashant Motiram Mulawkar; Gyanendra Sharma; Ashwin Tamhankar; Utsav Shah; Rickaz Raheem
Journal:  Front Surg       Date:  2022-02-21

6.  Flexible Cystoscopy in the Setting of Macroscopic Hematuria: Do the Findings Justify Its Use?

Authors:  Reuben Ben-David; Samuel Morgan; Ziv Savin; Snir Dekalo; Mario Sofer; Avi Beri; Ofer Yossepowitch; Roy Mano
Journal:  Urol Int       Date:  2021-07-20       Impact factor: 2.089

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.